幕上与幕下急性缺血性卒中预测结局的NIHSS截断值
本研究基于ENCHANTED试验阿替普酶剂量组数据,评估幕上(n=2,613)与幕下(n=289)急性缺血性卒中患者基线NIHSS预测90天不良结局(mRS 3-6分)的最佳截断值。幕上最佳截断值为10分(AUC 76,敏感度65%,特异度73%),幕下为6分(AUC 69,敏感度72%,特异度56%)。结论认为在溶栓 eligible 患者中,幕下病变相比幕上病变,相似恢复预后下NIHSS可能低估临床严重程度;当幕下AIS基线NIHSS>6分时溶栓对结局影响低,应考虑血管内治疗等额外治疗。
要点
- 幕上AIS预测不良结局的NIHSS最佳截断值为10分(AUC 76,敏感度65%,特异度73%)。
- 幕下AIS预测不良结局的NIHSS最佳截断值为6分(AUC 69,敏感度72%,特异度56%)。
- 幕下AIS基线NIHSS>6分时溶栓对结局影响低,作者建议考虑血管内治疗等额外治疗。
核心结论
- 在溶栓 eligible 的AIS患者中,相比幕上病变,幕下病变在相似恢复预后下NIHSS可能低估临床严重程度。
- 幕下AIS基线NIHSS>6分时溶栓对卒中结局影响低,作者建议考虑血管内治疗等额外治疗以改善结局。
研究设计与样本
- 数据来自随机对照试验ENCHANTED阿替普酶剂量组参与者。
- 临床定义幕上AIS患者n=2,613,幕下AIS患者n=289。
- 采用logistic回归模型评估基线特征与不良功能结局(mRS 3-6分)的关联,并以AUC-ROC确定最佳NIHSS预测截断值。
主要发现
- 幕下AIS患者基线NIHSS中位数7分 vs 幕上AIS患者9分(p<0.001)。
- 幕上AIS预测不良结局的NIHSS截断值为10分(AUC 76,敏感度65%,特异度73%)。
- 幕下AIS预测不良结局的NIHSS截断值为6分(AUC 69,敏感度72%,特异度56%)。
- 幕上AIS与幕下AIS之间功能结局或症状性颅内出血无显著差异。
关键数值与推荐
- 幕上AIS:NIHSS截断值10分,AUC 76,敏感度65%,特异度73%。
- 幕下AIS:NIHSS截断值6分,AUC 69,敏感度72%,特异度56%。
- 不良功能结局定义为改良Rankin量表评分3-6分。
临床怎么用
- 作者认为,幕下AIS基线NIHSS>6分时,可考虑血管内治疗等额外治疗以改善卒中结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the optimal cut point on the NIH Stroke Scale (NIHSS) for predicting poor 90-day clinical outcome in patients with supratentorial and infratentorial acute ischemic stroke (AIS). METHODS: Data are from participants of the alteplase-dose arm of the randomized controlled trial, Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED). Associations between baseline characteristics of clinically defined supratentorial and infratentorial AIS patients and poor functional outcome, defined by scores 3-6 on the modified Rankin Scale, were evaluated in logistic regression models, with area under the curve (AUC) receiver operating characteristics defining the optimal NIHSS predictor cut point. RESULTS: Patients with infratentorial AIS (n = 289) had lower baseline NIHSS scores than those with supratentorial AIS (n = 2,613) (median 7 vs 9; p < 0.001). NIHSS cut points for poor outcome were 10 (AUC 76, sensitivity 65%, specificity 73%) and 6 (AUC 69, sensitivity 72%, specificity 56%) in supratentorial and infratentorial AIS, respectively. There was no significant difference in functional outcome or symptomatic intracranial hemorrhage between AIS types. CONCLUSIONS: In thrombolysis-eligible AIS patients, the NIHSS may underestimate clinical severity for infratentorial compared to supratentorial lesions for a similar prognosis for recovery. Because thrombolysis treatment has low effect on stroke outcome in patients with infratentorial AIS when baseline NIHSS score is more than 6, additional treatment such as endovascular treatment should be considered to improve stroke outcome. CLINICALTRIALSGOV IDENTIFIER: NCT01422616.
引用
- Yoshimura S, Lindley RI, Carcel C, et al. NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke. Neurology. 2018. PMID: 30266885. doi:10.1212/WNL.0000000000006437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。